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Abstract
Purpose and background The focus was directed to the
study of two of the most lignan-rich food sources: sesame
and flaxseeds. Recent epidemiological and experimental
evidences suggesting that these foods may improve meta-
bolic functions underlying metabolic syndrome (MetS).
Methods To characterize the effect of these oilseeds on
metabolic functions, we conducted an experimental study
aimed at preventing adiposity and metabolic imbalance in a
mouse model of high-fat diet (HFD)-induced MetS. Sta-
tistical analysis was performed by two-way analysis of
variance test followed by post hoc Bonferroni analysis.
Results We studied the effect of the oilseeds sesame and
flaxseed on metabolic parameters in mice on a HFD. When
the HFD was integrated with 20 % of sesame or flaxseed
flours, the mice showed a decrease in body fat, already at
day 15, from time 0. The size of the adipocytes was smaller
in epididymal fat, liver steatosis was inhibited, and insulin
sensitivity was higher in mice on the supplemented diets.
The supplemented diets also resulted in a significant
increase in the serum levels of the lignan metabolites en-
terodiol and enterolactone compared with the controls. The
expression of genes associated with the inflammatory
response, glucose metabolism, adipose metabolism and
nuclear receptor were altered by the oilseed-supplemented
diets. Some of the most abundant lignans in these oilseeds
were studied in 3T3-L1 preadipocyte cells and were
effective in inhibiting adipocyte differentiation at the
minimal dose of 1 nM.
Conclusions The consumption of sesame and flaxseed
may be beneficial to decrease metabolic parameters that are
generally altered in MetS.
Keywords Oilseeds  Lignans  Metabolic syndrome 
Adipose deposition  3T3-L1 differentiation
Introduction
Lignans are chemicals produced as secondary metabolites
in plants where they are found mostly as aglycones, olig-
omers and glycosides [1, 2]. Their structure is determined
by the union of two cinnamic acid residues or their bio-
genetic equivalents. They occur in the whole plant king-
dom and can also be found in fiber-rich foods, typically
regarded as healthy foods. Dietary lignans are broadly
available and particularly concentrated in oilseeds (espe-
cially in flaxseed and sesame), in cereal grains (e.g., wheat
and rye bran) and nuts [3], Brassica species, legumes,
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berries, and in many plant-related beverages (tea, coffee,
wine) [1, 4–7]. Cereal brans, legumes and some seeds and
vegetables are suggested to be the most important sources
of lignans in the EU diets [8]. The average lignan intake in
the Finnish population (food frequency questionnaires:
n = 2,862) was estimated to be 434 lg/day (285 lg/day
for men and 601 lg/day for women) [9]. In a Dutch study
(food frequency questionnaires: n = 4,660), the average
daily intake of lignans was calculated to be 1,241 lg/day
[1]. Intakes between 850 and 5,816 lg/day have been
determined in central-south EU [10] and 760 lg/day in
Spain [11]. Higher intakes (up to 13.5 mg/day) have been
found in Germany [12]. Lignans are expected to have
beneficial effects in humans after fermentative conversion
in the colon to the mammalian lignans ENL and END [13,
14]. Subpopulations with higher consumption of lignans
display considerable lower disease frequency [7, 15–22]. In
several studies, lignan-rich foods, concentrates or partially
purified compounds have been shown to improve blood
lipids, to enhance glycemic control and to alleviate or cure
type 1 and type 2 diabetes [23–27]. However, the results
produced in these studies, although very promising, were
not homogeneous due to their different and often frag-
mented approaches. The identified variables were as fol-
lows: the source of the lignans and other factors in the
food, the doses of compounds in different preparations
(extracts or whole grains), the time of intake, the targeted
cohorts, the analyzed end-points and the methods of ana-
lysis [28]. Some mechanistic studies have also been per-
formed identifying the lignans mainly as efficient
antioxidants and phytoestrogenic compounds [29–31].
The present work is based on recent epidemiological and
experimental evidences, suggesting that lignan-rich foods,
such as oilseeds, may improve metabolic functions under-
lying metabolic syndrome (MetS) [17, 22, 29, 32–34]. The
focus was directed to study two of the most lignan-rich food
sources: sesame and flaxseeds, which contain up to 1 %
lignans (500–1,000 mg/100 g) [35, 36]. Sesame seeds
contain several lipophilic (sesamin (SES), sesaminol, se-
samolinol and sesamolin), as well as hydrophilic lignans [7-
hydroxymatairesinol, pinoresinol (PIN), medioresinol
(MED), matairesinol (MR), lariciresinol (LAR), cyclola-
riciresinol (CLAR), a-conidendrin and 7-oxomatairesinol],
while flaxseed contains mainly secoisolariciresinol dig-
lucoside, which composes 98 % of the lignans in this seed
[36]. A few other lignans have recently been identified in
food sources, of which, to our knowledge, no biological
studies have been conducted: for example todolactol A [3,
37], saminol and episesaminone sophoroside [37], seco-
isolariciresinol (SEC) and lariciresinol sesquilignans and
iso-hydroxymatairesinol (iso-HMR) [3].
To characterize the effect of these oilseeds on meta-
bolic functions at the basis of MetS, we conducted an
experimental study in a mouse model of HFD-induced
MetS. Furthermore, the most concentrated hydrophilic
lignans in the studied materials were characterized as sin-
gle molecules in a cellular model of induced adipogenesis.
Materials and methods
Experimental animals
The procedures involving animals and their care were con-
ducted in accord with institutional guidelines, which comply
with national and international laws and policies (National
Institutes of Health, Guide for the Care and Use of Laboratory
Animals, 1996 (7th ed.) [Washington, DC]; National Acad-
emy Press, National Research Council Guide, www.nap.edu/
readingroom/books/labrats). Three-week-old C57BL/6J male
mice (Harlan, Udine) were kept in animal rooms maintained
at a temperature of 23 C, with natural light/dark cycles. The
animals were killed by cervical dislocation, and the tissues
were dissected and immediately frozen on dry ice.
Diets
Low-fat (LFD) and high-fat (HFD) diets containing 10 and
50 % fat, respectively, were purchased by Piccioni (Milan,
Italy). Importantly, a careful calculation of the final total
fat present in the diets was made. The sesame-supple-
mented diets (SSD) and flaxseed-supplemented diets (FSD)
were isocaloric and prepared to contain the same amount of
total fat as for the HFD. The different amount of calories of
sesame and flaxseed was compensated by adjusting the
component of lard (Table 1).
Chemicals and seeds
The lignans SEC, PIN, CLAR and LAR were prepared at
A˚bo Akademi University (Laboratory of Wood and Paper
Chemistry) as described previously [3], and SES was from
Sigma (Pomezia, Italy). The chemicals were dissolved in
DMSO and further diluted before their addition to the 3T3-
L1 culture medium, for homogeneous preparations. The
seed samples were obtained from: ‘‘Il Campicello del Bi-
ologico and Biopack s.a.s. (Turin, Italy)’’. Table 2 lists the
composition of sesame and flaxseed. The specific lignans
composition is described in Table 3, and it is in accordance
with quantification reported in the literature [38].
EchoMRI analysis
Echo Magnetic Resonance Imaging system (EchoMRI)
(Medical System, Houston, TX), provides the most precise
measurements of whole body composition parameters
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(total body fat and lean mass), in living mice without the
need of anesthesia or sedation and in \1 min. Alterations
in mouse whole body composition were assessed as a result
of exposure to the diets. Measurements of fat and lean mass
and body weight were made twice a week for the whole
period of the study.
Standard protocol: The EchoMRI-100TM QNMR system
was housed in a dedicated area to minimize the entry of
disease or contaminants. Prior to each QNMR run, the
system was calibrated using a standard provided by Echo
Medical System. Each mouse was placed into an appro-
priate size tube and placed in the QNMR instrument for
measurements. The mouse was subjected to a predeter-
mined sequence of radio frequency energy during a 47 s
run. Three sequential independent scans were conducted
for each mouse, and the data were automatically trans-
ferred to the database. The output information was
expressed as lean tissue mass and fat mass in grams.
Insulin tolerance tests
For insulin tolerance tests, fed animals were used. Animals
were injected intraperitoneally with 0.75 IU/kg body
weight of soluble insulin (Humulina Regular, Lilly,
Madrid). Blood glucose was measured in each sample
using an Accu-Chek compact glucometer (Roche Diag-
nostic GmbH, Mannheim, Germany). Insulin concentration
was assayed by a standardized mouse insulin assay (Cat.#
EZRMI-13 K; Millipore, Milan).
Table 1 Composition of diets fed to mice for 84 days
Low-fat diet
(10 % calories from fat)
High-fat diet
(50 % calories from fat)
High-fat diet plus 20 %
sesame
High-fat diet plus 20 %
flaxseed
20.0 % casein 25.0 % casein 19.5 % casein 19.0 % casein
0.3 % L-cysteine 0.3 % L-cysteine 0.3 % L-cysteine 0.3 % L-cysteine
25.0 % mais starch 10.8 % mais starch 6.2 % mais starch 6.0 % mais starch
8.5 % maltodextrins 5.0 % maltodextrins 5.0 % maltodextrins 5.0 % maltodextrins
31.5 % sucrose 20.5 % sucrose 23.0 % sucrose 21.0 % sucrose
5.0 % cellulose 5.0 % cellulose 3.3 % cellulose 4.6 % cellulose
2.5 % mais oil 2.5 % mais oil 2.5 % mais oil 2.5 % mais oil
2.0 % lard 13.0 % Lard plus 12.5 % hydrogenated coconut Oil 14.8 % lard 16.2 % lard
4.0 % mineral mix 4.0 % mineral mix 4.0 % mineral mix 4.0 % mineral mix
1.0 % vitamin mix 1.0 % vitamin mix 1.0 % vitamin mix 1.0 % vitamin mix
0.2 % colin bitartrate 0.4 % choline chloride 0.4 % choline chloride 0.4 % choline chloride
/ / 20.0 % sesame 20.0 % flax seed
Low-fat (LFD) and high-fat (HFD) diets containing 10 % and 50 % fat, respectively, were purchased from Piccioni (Milan, Italy). Importantly, a
careful calculation of the final total fat present in the diets was made
The sesame- and flaxseed-supplemented diets were isocaloric and prepared from Piccioni to contain the same amount of total fat as for the HFD
Table 2 Composition of sesame and flaxseed in percent
Composition of sesame Composition of flaxseed
Ingredient Percent Ingredient Percent
Water 8 Water 8
Protein 22.3 Protein 25
Fat 42.9 Fat 36
Fiber 9.0 Fiber 5.5
Ash 5.6 Ash 4.5
Nitrogen free extract 12.2 Nitrogen free extract 24.0
Total lignans 1 Total lignans 0.5
Table 3 Concentration of lignans in extract of milled flaxseeds and
sesame
Lignan (lg/100 g) Flaxseeds Sesame seeds
Hydroxymatairesinol nd 9,021
Secoisolariciresinol 690,757 61.78
Matairesinol 42.35 773.0
Lariciresinol 335.2 5,445
Cyclolariciresinol 8,260 595.0
Pinoresinol 401.5 13,065
Medioresinol nd 1,913
Syringaresinol nd nd
Sesamin nd 42,415
a-Conidendrin 25.21 253
7-Oxomatairesinol nd 159.6
7-Hydroxysecoisolariciresinol 997 nd
Secoisolariciresinol sesquilignan 2,036 nd
Total 702,854 73,701
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3T3-L1 cell culture
Mouse 3T3-L1 fibroblasts (American Type Culture Col-
lection) were maintained as subconfluent culture by pas-
sage every 3 days from culture seeded at 5,000 cells/cm2 in
Dulbecco’s modified Eagle’s medium (DMEM) containing
10 % calf serum (Invitrogen). Cells were maintained at
37 C in a humidified 5 % CO2 atmosphere.
3T3-L1 adipocyte differentiation assay
For differentiation assay, 3T3-L1 cells were seeded at
5 9 103 cells per well into 24-well tissue culture plates in
DMEM containing 10 % calf serum. Two days after having
confluence (D0), the cells were treated with vehicle
(DMSO or absolute ethanol) or test chemicals such as SEC,
LAR, CLAR, PIN and SES, either in basal medium (BAS)
(DMEM containing 10 % calf serum) or in differentiation
medium (MDI) (DMEM containing 10 % fetal bovine
serum, 167 nM insulin, 0.5 mM isobutylmethylxanthine
and 1 mM dexamethasone) for 2 days (D2). Cells were
then maintained for further 2 days (D4) in BAS or in MDI
medium supplemented only with 167 nM insulin. The
medium was changed every 2 days. On the day 9 after
treatment, adipocyte differentiation was quantified by using
the commercially available adipogenesis assay kit (Milli-
pore) according to the manufacturer’s instructions. Briefly,
cells were stained with Oil Red O solution (0.36 in 60 %
isopropanol) for 15 min; a wash solution was provided to
remove free Oil Red O from the cell layer, and finally,
lipid-bound Oil Red O was extracted with a dye extraction
solution and measured at 520 nm in a spectrophotometer.
For each chemical test, three independent experiments
were performed. The average of these determinations has
been calculated through the appropriated statistical
analysis.
Determination of plant lignans in sesame and flaxseed
and of enterodiol and enterolactone in mouse serum
The concentration of major hydrophilic lignans present in
the sesame and flax seeds from organic cultures (Il
Campicello del Biologico and Biopack s.a.s., Turin, Italy)
used in the experiments were measured by high-perfor-
mance liquid chromatography–tandem mass spectrometry
(HPLC-MS/MS) [3]. END and ENL were determined by
HPLC-MS/MS in the mouse serum samples after enzy-
matic hydrolysis and solid-phase extraction according to a
previously described method [39]. The method was slightly
modified by taking 50 ll of serum instead of 600 ll and
290 units of b-glucuronidase/sulphatase dissolved in 0.5 ml
of 10 mM of sodium acetate buffer (pH 5.0) for each
sample (for the enzymatic hydrolysis).
RNA extraction and expression analysis with TaqMan
microfluidic cards
Total RNA was extracted from 10 to 30 mg of tissue using
the RNeasy Lipid Tissue Kit (Qiagen, Maryland, USA) and
following the manufacturer’s instruction. RNA purity and
integrity was assessed with denaturing gel electrophoresis.
RNA for each sample was reversed transcribed using high-
capacity cDNA Archive Kit (Applied Biosystems, Foster
City, CA) with a master mix containing 2.5 U/ll of Mul-
tiScribe reverse transcriptase and 1 lg of total RNA. The
reaction mixture was incubated at 25 C for 10 min, fol-
lowed by 120 min at 37 C, and then heat inactivation of
the enzyme at 85 C for 5 s. Two microliters of single-
stranded cDNA were mixed with 48 ll of nuclease-free
water and 50 ll of TaqMan Universal PCR Master Mix.
After loading 100 ll of the sample-specific PCR mixture
into one sample port of the microfluidic cards, the cards
were centrifuged twice for 1 min at 280 g and sealed to
prevent well-to-well contamination. The cards were placed
in the microfluidic card Sample Block of an ABI Prism
7900 HT Sequence Detection System (Applied Biosys-
tems). The thermal cycling conditions were 2 min at 50 C
and 10 min at 95 C, followed by 40 cycles of 30 s at
97 C and 1 min at 59.7 C. The assay for each gene was
carried out in triplicate. The calculation of the threshold
cycle (Ct) values was performed using the SDS 2.2 soft-
ware (Applied Biosystems), after automatically setting the
baseline and the threshold. The 96 genes Low density
Array (LDA) cards were designed containing key genes of
metabolic pathways involved in adipose and glucose
metabolism, inflammation and nuclear receptor signaling.
18S RNA was used as the reference housekeeping gene.
Specific oligonucleotide pairs were designed by the
Applied Biosystems service.
Histological examination
Epididymal adipose tissue was fixed in formaldehyde and
embedded in paraffin. Three-micrometer sections were
dewaxed and rehydrated through decreasing alcohol series
up to distilled water and stained with hematoxylin–eosin to
examine cellular architecture and lipid vacuoles. Original
magnification was 409. A pathologist blinded to the
treatment groups conducted a histological analysis of the
liver sections. Fat content in the liver was quantified by the
adipogenesis assay kit (Millipore). Adipocyte size was
quantified measuring the cell area using dedicated software
(Image Pro Plus; Imaging and Computer, Milan). In all
samples, five different fields of the same tissue section
were evaluated. Data represent the average results of five
different mice. Data are shown as mean ± SD.
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Statistical analysis
Statistical analysis of the in vivo data was performed by two-
way analysis of variance test followed by post hoc Bonfer-
roni analysis. In vitro data were analyzed by one-way ana-
lysis of variance (ANOVA) comparing to the control.
Results
Effects of oilseed-supplemented diets on body fat
deposition in male mice
Three-week-old male mice were exposed to a low-fat diet
(LFD 10 %), a high-fat diet (HFD 50 %) or a high-fat diet
containing 20 % sesame (SSD) or 20 % flaxseed (FSD)
flours. Total body fat and total body weight were measured
periodically for 84 days. From day 3 until the end of the
experiment, the fat mass was significantly lower in mice
fed the SSD or FSD diets compared to the mice on the HFD
(Fig. 1a). The same result was obtained when fat mass was
normalized to the body weight (Fig. 1b). Weak differences
were observed in the lean mass and body weight (slightly
decreased in mice fed the supplemented diets), which
however did not reached statistical significance (Fig. 1c).
Food consumption was not significantly different among
the groups (not shown).
Effects of oilseed-supplemented diets on single fat pads
To confirm the results observed through the measurement
of total fat mass by EchoMRI, we also isolated and
weighed epididymal and renal fat pads in the same animals
that undergo killing. The data shown in Fig. 2 (Fig. 2a, b)
confirm that the epididymal and renal fat pads are signifi-
cantly smaller in the SSD- and FSD-treated mice compared
to the mice on the HFD alone. Insulin sensitivity was
improved and the need of insulin production and secretion
decreased in the oilseed-treated compared to vehicle-trea-
ted mice (Fig. 2c, d). Histological examination of the
adipocyte size in epididymal fat revealed that the decrease
in fat weight of mice fed the SSD or FSD diets, correspond
to a decreased cell volume (Fig. 3a). Adipocyte size was
quantified measuring the cell area using suitable software.
In all samples, five different fields of the same tissue sec-
tion were evaluated (Fig. 3b). Mice on the high-fat diet
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Fig. 1 Effect of sesame- and flaxseed-supplemented diets on fat
development in male mice. Time course effects of control LFD,
control HFD, 20 % sesame containing diet SSD and 20 % flaxseed
containing diet FSD on total adipose tissue development, in 3-weeks-
old male C57BL/6J mice. Adipose tissue development was analyzed
using an EchoMRI system (Huston, TX). a Total body fat. b Adipose
tissue development normalized on total body weight (grams of fat/
grams of total body weight). c Body weight. Time of treatments
84 days. Data represent the average of total fat weight from 10 mice
per group ± SE, p \ 0.05, or \ 0.001 as compared with the fat mass
of mice on the HFD alone. At all the measured time points, the
difference between total fat in mice fed the HFD is significant with
respect to the mice on the LFD (p \ 0.001) starting from day 15
(square LFD; circle HFD; triangle HFD plus 20 % sesame flour;
rumble HFD plus 20 % flaxseed flour)
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developed accumulation of lipid droplets in the liver (liver
steatosis) that were measured by histological analysis
(Fig. 4a). Fat content was quantified (Fig. 4b). In the sub-
groups of mice on the 20 % sesame (SSD) and 20 %
flaxseed (FSD) integrated diets, the lipid content in the
liver was not significantly different from the liver of mice
on the LFD.
Levels of plant lignans in seed samples and mammalian
lignans (ENL, END) in mouse serum
The lignan concentrations present in hydrophilic extracts of
the sesame and flaxseeds used in the experiments as
assessed by HPLC-MS/MS and shown in Table 3. In
flaxseed, the total lignan concentration is 703 mg/100 g, in
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Fig. 2 Effect of sesame and
flaxseed integrated diets on
epididymal and renal fat weight.
At the end of the treatments
(84 days), the mice were killed
and the organs collected.
Adipose tissue deposition was
analyzed through the weight of
a epididymal and b renal fat
pads. ap \ 0.05 versus LFD,
cp \ 0.05 versus HFD. Data
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Fig. 3 Histological examination of adipocytes. Epididymal adipose
tissue was fixed in formaldehyde and paraffin embedded. Sections
(3 lm), dewaxed and rehydrated through decreasing alcohol series up
to distilled water, were stained with hematoxylin–eosin. a Cells were
photographed at 209 magnification with a digital camera (Nikon
Digital Camera DMX 1200). b Cell area was measured using
dedicated software (Image Pro Plus; Imaging and Computer, Milan).
In all samples, five different fields of the same tissue section were
evaluated. Data represent the average results of five different mice.
Data are shown as mean ± SD. *p \ 0.05
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sesame 74 mg/100 g. It should be noted that sesame seeds
are known to contain high concentrations of lipophilic
lignans. SES, which is the main lipophilic lignan, was
found at the highest lignan concentration of 42,415 lg/
100 g of sesame seeds. A lower amount if compared to its
concentration in sesame oil that ranges from 7,000 to
712,000 lg/100 g seed [40]. SES is efficiently metabolized
in vivo, giving large amounts of mammalian lignans.
Nortrachelogenin, lariciresinol sesquilignan and 4,40-
dimethyl matairesinol could not be detected in any of the
samples. The lignan metabolites ENL and END, produced
by the intestinal microbiota from the dietary precursors,
were also measured in the mouse serum by HPLC-MS/MS.
As reported in Fig. 5, the sera of mice fed the SSD and
FSD have significantly higher levels of the metabolites
(506 nM END and 336 nM ENL, 1,116 nM END and
113 nM ENL, respectively) compared to the mice on the
synthetic LFD (50 nM END and 14 nM ENL) and HFD
(46 nM END and 46 nM ENL). The small amount of ENL
and END measured in mice on the control LFD and HFD
diets probably reflects the consumption of a certain amount
of sawdust, which contains several lignans of wood
(unpublished) that are metabolized into enterolignans.
Changes in metabolic pathways in the visceral fat
Increased adipose deposition in visceral fat pads is asso-
ciated with changes in several metabolic parameters. We
analyzed the deregulation of the expression of sets of genes
involved in fat accumulation, insulin resistance/glucose
metabolism, adipocyte metabolism, inflammation and
genes of the nuclear receptors (NRs) family involved in
adipocyte signaling. Relative mRNA quantification for
specific genes was based on TaqMan microfluidic cards
and was normalized to the expression of 18S reference
gene relative quantification.
The genes that were found to be modulated, when
compared with HFD in our assays, codify for members of
the glucose metabolism [insulin receptor substrate-1 (Irs1),
melanocortin receptor 4 (Mc4r), insulin-like growth factor
2 (Igf2), IGF-binding protein-5 (Igfbp5)], adipocyte
metabolism [leptin (Lep), lipin 2 (Lpin2), phospholipid
transfer protein (Pltp), acetyl-CoA carboxylase-a (Acaca),
acyl-CoA dehydrogenase long chain (Acadl), adiponectin
(Adipoq), apolipoprotein C2 (Apoc2), fatty acid-binding
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Fig. 4 Liver steatosis. Representative liver sections stained with
hematoxylin and eosin. a Livers from LFD-treated mice exhibited
normal hepatic architecture, whereas HFD livers revealed micro- and
macrovesicular steatosis. SSD and FSD livers show some vacuoles,
although much less that HFD mice; b liver tissue was processed for
the Adipogenesis assay to quantify the fat content. Percent fat content
was determined relative to fat content in the liver of mice on the LFD
diet. Livers from mice on the HFD diet alone showed 6 times more fat
than mice on the LFD diet. Mice on the sesame- and flaxseed-
supplemented diet exhibited a fat concentration not significantly
different from that of the mice on the LFS diet. Data are shown as
mean ± SE (*p \ 0.05; **p \ 0.001)
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Fig. 5 Serum levels of enterodiol and enterolactone. Serum levels of
ENL and END were measured by HPLC–MS/MS. Values are
expressed as nM of substance in serum. The experiments were
repeated twice with five mice for each group. Bars represent the
average ± SEM. *p \ 0.05 versus HFD, **p \ 0.001 versus HFD
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protein 7 (Fabp7), phospholipase A2 group 7 (Pla2g7)] and
inflammation [tumor necrosis factor alpha (TNFa),
Inflammatory response lipoate synthase (Lipa) and albu-
min] (Fig. 6). The expression of genes involved in
inflammatory response, Albumin and Lipa were signifi-
cantly down-regulated by diet containing oilseeds, inter-
estingly a consistent up-regulation (250-fold) of the
inflammatory mediator TNFa caused by the HFD and its
inhibition down to basal levels by both the SSD and FSD
diets, was observed (Fig. 6a).The genes regarding glucose
metabolism were regulated in different manner; Irs1 was
significantly down-regulated with FSD, while Mc4r by
SSD; Igf2 and Igfbp5 both augmented their expression, the
first one in more evident mode by FSD and the second one
by SSD. Among the genes involved in adipose metabolism
Lep and Lpin2 showed inhibition of the expression both
SSD and FSD; Acaca, Adipoq, Fabp7 and Pla2g7 were up-
regulated by SSD and FSD, while Acadl and ApoC2 aug-
mented significantly their expression only by FSD. Sesame
and flaxseed are very rich in lignans that have been shown
to act through the activation of NRs; thus, we also mea-
sured the regulation of NRs involved in metabolic cell
functions [estrogen receptor alpha (Era), estrogen receptor
beta (Erb), peroxisome proliferator-activated receptor
gamma 1 (Pparc1), progesterone receptor (Pr), cholesterol-
sensing nuclear receptor (Lxrb), retinoidX receptor alpha
(Rxra)]. Interestingly, Era, and much more strongly Erb,
was up-regulated by flaxseed and to a lesser extent by
sesame, Pr was up-regulated by FSD, but down-regulated
with SSD. Typically regarded as key NRs for metabolic
signaling in fat and liver cells, as Lxrb and with smaller
effect Pparc1, were less expressed, while Rxra was up-
regulated, with slightly greater effect by sesame compared
with flaxseed (Fig. 6d).
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Fig. 6 Changes in metabolic
pathways in the epididymal fat.
Analysis of the gene expression
patterns in epididymal fat.
Relative mRNA quantification
for specific genes was based on
TaqMan, LDA microfluidic
cards. The expression of sets of
genes involved in
a inflammation, b insulin
resistance/glucose metabolism,
c adipose metabolism, d nuclear
receptors was quantified. The
expression of target genes was
normalized to the expression of
18S reference gene (relative
quantification). Mice were
treated with HFD or HFD plus
SSD or plus FSD. Vehicle (dark
gray bars), sesame (light gray
bars), flaxseed (white bars).
Values represent the fold
induction over the control
(LFD). The experiments were in
triplicate. Bars represent the
average ± SEM. *p \ 0.05
versus HFD, **p \ 0.001
versus HFD
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Effects of lignans on 3T3-L1 differentiation
The in vivo results indicate that sesame and flaxseed are
antiadipogenic and anti-inflammatory foods. Lignans
compose about 0.5–1 % of the compounds present in these
oilseeds (w/w) and are the most abundant polyphenols.
According to our measurements (see ‘‘Materials and
methods’’ section, Table 2) and to the literature [38], SEC
and CLAR are mostly abundant in flaxseed and SES, LAR
and PIN abundant in sesame (Table 3). Being aware of the
fact that several other compounds present in these oilseeds
may play an antiadipogenic role (omega-3, fiber, vitamins,
etc.), we tested in vitro the contribution of both hydrophilic
(SEC, CLAR, LAR, PIN) and lipophilic (SES) lignans as
single molecules on the 3T3-L1 in vitro model of adipocyte
cell differentiation. Cells were treated for 48 h with vehicle
only (ctr) or different lignans (as single molecules) in BAS
or in the MDI. On the day 9 after treatment, lipid content
was measured by the adipogenesis assay. All the lignans
tested were effective, although to a different extent in
reducing lipid content. Some (PIN, LAR, CLAR) already at
nM doses confirming their antiadipogenic role (Fig. 7). We
did not observe signs of cell toxicity at the used doses.
Discussion
In this study, we show that supplementation of HFD with
20 % sesame or flaxseed flour significantly decreases the
fat mass in C57BL/6J male mice and to a lesser extent also
whole body weight, although this change did not reach
significance. This effect was observed already after
2 weeks from the beginning of the treatments, while some
difference in body weights started to be visible at 30 days.
A clear decrease in the fat mass was also confirmed by the
analysis of isolated epididymal and renal fat pads, by the
measurement of the adipocyte size and by a decrease in
liver steatosis. In mice, the supplemented diets led to an
increase in ENL and END blood levels, indicating that the
lignans present in these seeds were absorbed and metabo-
lized and could be the contributors to the amelioration of
MetS, as observed in the treated mice. The changes in
a b
c d
e
Fig. 7 Effect of lignans on
3T3-L1 differentiation. 3T3-L1
cells were maintained in
DMEM containing 10 % calf
serum. Two days after reaching
confluence, the cells were
treated for 48 h with vehicle
(ctr) or the indicated lignans:
a PIN, b CLAR, c LAR, d SEC
and e SES in the basal medium
(ctr-, BAS) or in the
differentiation medium (ctr?,
MDI). The cells received fresh
medium every 48 h. On the day
9 after treatment, lipid content
was measured as described in
‘‘Materials and methods’’.
Ordinate value represents the
lipid content expressed as % of
the control. Each value is the
mean ± SD of three different
determinations. ap \ 0.05
versus ctr-, bp \ 0.001 versus
ctr-, cp \ 0.05 versus ctr?,
dp \ 0.001 versus ctr?
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adipose mass were associated with changes in insulin
sensitivity, which was enhanced by both SSD and FSD
diets and correlated with the increased levels of ENL and
END. Twenty percent of sesame or flaxseed in the exper-
imental diets used might be considered a high amount for
typical western diets. However, if consistent amount of
sesame in the order of tens of grams/meal is consumed, it
might be close to human intake when consuming Middle
Eastern diets, where sesame can be eaten in form of spread
(tahina) or dietary oil [35], although the form of the sesame
preparations may affect the absorption of lignans [41].
Flaxseed can also be consumed at higher amount in far
eastern diets as boiled seeds and as flour in bread or bis-
cuits [36]. Sesame and flaxseed contain 42.9 and 36 % fat,
respectively (see Table 2), which were considered in our
calculations to have final isocaloric diets. We believe that
the fat component in the total diet is important to make the
lignan absorbable and bioavailable, since most of the
lignans in sesame are lipophilic. A few authors who used
defatted sesame or flaxseed reported that also non-lipo-
philic components may improve lipid profiles in experi-
mental animals [42–44], although the results were not
supported by other studies [45]. In this study, the amount of
the ENL and END metabolites found in serum of our mice
at the end of the experiments was in line with the con-
centrations found in serum of people consuming flaxseed or
sesame as whole seeds or flours [46, 47], thus showing that
our diets supplementation simulated a real dietary intake.
Beyond these systemic actions, SSD and FSD diets
showed profound effects on metabolic parameters through
the regulation of gene pathways controlling glucose and
adipose metabolism, inflammation and nuclear receptor
signaling in visceral fat. Changes in adipose metabolism
were evidenced at molecular level through the measure-
ment of the expression of related genes. Leptin and Lpin2
were inhibited by the oilseeds, while the expression of Pltp
was decreased in FSD but not with SSD. The genes Acaca,
Adiponectin, Fabp7 and Pla2g7 were induced, while the
expression of Acadl, Apoc2 was increased at substantial
level only in FSD. Among the induced genes, adiponectin
was up-regulated threefold and fourfold. Adiponectin lev-
els have been shown to be associated with insulin-like
growth factor-binding protein-5 (IGFBP-5), which modu-
lates the insulin growth factor (IGF) signaling pathway in
human subjects [48]. IGFs are important determinants of
metabolic functions; thus, the recent identification of
modulators of IGF bioactivity is of high interest. A major
regulatory action is exerted by six IGF-binding proteins
(IGFBP-1 to 6), which show high affinity for IGFs [49, 50].
The IGF/IGFBP complexes prolong the half-lives of IGFs
and thus may buffer the potential hypoglycemic effects that
could result from high concentrations of circulating
unbound IGFs [51]. IGFBP-5 is thus a key gene of glucose
metabolism and has been shown to be associated with
control of adiposity and is supposed to mediate a mecha-
nism used to limit further fat gain [50]. In our experiments,
IGFBP-5, as well as IGF-2, is strongly up-regulated by
both the supplemented diets. These results point out the
importance of compounds present in oilseeds in the control
of glucose metabolism through IGFs and IGFBPs, stimu-
lating further research aimed at providing detailed mech-
anistic insights.
The positive and negative association, respectively, of
leptin and adiponectin expression with fat mass is well
known [52]. The variations on adipokines expression in
mice fed the oilseed-supplemented diets followed this
trend. However, the effects of oilseed on the metabolic
parameters analyzed are not uniform in the literature. In a
work performed in rabbits [53] reported a flaxseed-
dependent induction of leptin, which positively correlated
with levels of alpha linolenic acid (ALA) and inversely
with atherosclerosis. These apparently contrasting associ-
ations underline the need for further research on the effects
of dietary oilseeds on metabolic regulation.
Different nuclear receptors mediate the cell response to
chemicals contained in food. Among these, the estrogen
receptors ERa and ERb have been shown to be activated
by the mammalian lignans ENL and END [31, 54]. We
here found that ER expression is induced in epididymal fat
by sesame and flaxseeds, suggesting that their effect on fat
mass deposition might have been produced through a
mechanism that involves an estradiol-mimicking action. A
stronger induction was observed for ERb, which is actually
the ER isotype more responsive to phytoestrogenic com-
pounds [55]. However, in light of the most recent pro-
gresses in the area of the study of natural ligands for the
ERs from nutritional sources, the term ‘‘phytoestrogen’’
appears to be inadequate or poorly representative of the
actual activity of the lignans, when considering metabolic
functions as functional targets. The reason is that it is
becoming frequent to observe that the same molecules that
bind and activate the ERs, also bind and activate other NRs
that may play opposite actions on the regulation of target
genes (i.e., PPARc) and activate NR cross-talks with out-
comes that are not clear [31, 56, 57]. An example of a
lignan that binds the PPARs is macelignan [58, 59], which
has been determined as a dual ligand for PPARa/c recep-
tors. Macelignan improves insulin sensitivity in obese
diabetic (db/db) mice and increases insulin secretion in the
b-cell line MIN6, highlightening lignans as potential reg-
ulators of insulin release [60]. The mechanism underlying
the coexisting activities of lignans as estrogen mimics, and
at the same time, regulators of other NRs, such as PPARs,
and LXRs, remain an open issue. Through a large com-
puter-based screening of lignans using in silico techniques,
compounds that may bind to other NRs have been selected.
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Using the structure of the ligand-binding domain of the
LXR receptor (1PQ8, 1PQ6, 1PQC, 1UPV) [61], two
lignans that display all characteristics of high-affinity
ligands, MR and Secoisolariciresinol esquilignan Digly-
coside (SDG), have been identified. In cell-dependent
assays, MR and SDG were able to activate the expression
of several LXR regulated target genes, both in colon and in
liver cells (personal communication). Both LXRb and
PPARc are down-regulated by sesame and flaxseed in the
liver and adipocytes, respectively, suggesting an effect on
the synthesis of triglycerides and adipocyte differentiation.
Last but not least, all mentioned NRs are involved in
decreasing the inflammation process through inhibition of
inflammatory pathways/genes. Adipose accumulation is
associated with increase expression of inflammatory genes.
TNFa showed a strong induction (up to 250-fold) by the
high-fat diet. When the oilseeds were added to the high-fat
diet, they restored the level of TNFa expression down to
the level found in mice fed the low-fat (10 %) diet, indi-
cating an efficient amelioration of the diet-induced
inflammation. Activated ERs, PPARs and LXRs are effi-
cient inhibitors of NF-kB [62–64], suggesting that the anti-
inflammatory activity of lignans (as evidenced in Fig. 5)
might also involve these NRs.
Here, we show that lignans, which are the most abun-
dant polyphenols (1 % w/w) (Table 3) in the oilseeds
sesame and flaxseed, are functional components. To get
insights into their activity on fat cells, we studied a few
lignans found to be abundant in flaxseed and sesame at
range of doses that are consistent with those obtained
through the diet (real-life doses). Most of the tested lignans
were able to inhibit the induced adipogenesis in 3T3-L1
cells, although with a different efficiency. CLAR, LAR and
PIN, the last one with less clear effect, were the most
efficient, being active at the lowest doses utilized
(1–10 nM range), while SEC and SES started to be active
at 10 nM showing a consistent potential for all these
compounds on fat cell differentiation. Although these
in vitro data support a role of the lignans in producing the
effects observed in vivo, beyond the lignans, sesame and
flaxseed contain consistent amounts of fibers, heteroge-
neous chemicals and functional compounds that may have
contributed to the effects observed in vivo. The omega-3
fatty acid, ALA, is the most abundant fatty acid in flaxseed,
and it is known to play a role in the regulation of leptin
blood levels [53].
Impressive advances have been seen in the last years
with regard to the identification of mechanisms of action
for the most thoroughly investigated dietary polyphenols
(lignans, stilbenes, isoflavones, etc.), and most of their
health-related effects have been attributed to their activity
as antioxidants [29, 30]. A certain amount of data are now
becoming available on the activity of these compounds at
doses lower than those required to exert antioxidant
activities, but sufficient to activate fundamental cell path-
way-regulating metabolic functions [18, 19, 22, 65, 66].
Thus, the understanding of the possible health effect of
lignans on the pathophysiological model of MetS has to go
through the comprehension of their action as regulators of
key factors that are central to metabolic pathway-regulating
fat biosynthesis, fat storage and accumulation, glucose
homeostasis, insulin biosynthesis and secretion, insulin
sensitivity, cholesterol biosynthesis and secretion, and low
chronic inflammation, which is the underlying contributor
to the worsening of adipose metabolism and function [67,
68].
Conclusions
In conclusion, sesame and flaxseed show the properties of
functional foods effective in ameliorating metabolic
parameters that are altered in the MetS. The lignans rep-
resent one of the major groups of natural plant chemicals
recommended to the consumer for their hormone-mim-
icking activities and amelioration of metabolic parameters,
but a clear understanding of their mechanisms on health is
still lacking. Nevertheless, lignan-based nutraceuticals are
already on the market, indicating that this class of com-
pounds deserves an urgent, multidisciplinary research to
validate their healthy properties.
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